Ingebjørg Knutsen

578 total citations
9 papers, 445 citations indexed

About

Ingebjørg Knutsen is a scholar working on Immunology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Ingebjørg Knutsen has authored 9 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 4 papers in Genetics and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Ingebjørg Knutsen's work include T-cell and B-cell Immunology (5 papers), Immune Cell Function and Interaction (5 papers) and Diabetes and associated disorders (4 papers). Ingebjørg Knutsen is often cited by papers focused on T-cell and B-cell Immunology (5 papers), Immune Cell Function and Interaction (5 papers) and Diabetes and associated disorders (4 papers). Ingebjørg Knutsen collaborates with scholars based in Norway, India and Denmark. Ingebjørg Knutsen's co-authors include Erik Thorsby, Anne Spurkland, Ludvig M. Sollid, G. Ingvarsson, Dag E. Undlien, E S Falk, Oddmund Sövik, Knut Dahl‐Jørgensen, Thomas Friede and Hans‐Georg Rammensee and has published in prestigious journals such as Diabetes, International Journal of Cancer and Human Immunology.

In The Last Decade

Ingebjørg Knutsen

9 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ingebjørg Knutsen Norway	7	165	160	159	108	105	9	445
S. Saarinen Sweden	6	159 1.0×	127 0.8×	127 0.8×	211 2.0×	69 0.7×	7	519
Simone Pasini Italy	8	74 0.4×	103 0.6×	108 0.7×	102 0.9×	30 0.3×	12	394
D. P. Jewell United Kingdom	6	109 0.7×	86 0.5×	170 1.1×	139 1.3×	70 0.7×	11	335
J Paris France	7	184 1.1×	26 0.2×	55 0.3×	169 1.6×	103 1.0×	11	425
Elizabeth A. Bidwell United Kingdom	8	37 0.2×	254 1.6×	117 0.7×	41 0.4×	23 0.2×	12	372
SE Marshall United Kingdom	10	63 0.4×	207 1.3×	124 0.8×	51 0.5×	7 0.1×	12	461
Yasunori Ichiki Japan	11	85 0.5×	141 0.9×	45 0.3×	291 2.7×	14 0.1×	21	502
Simon Hirschmann Germany	13	92 0.6×	274 1.7×	350 2.2×	191 1.8×	46 0.4×	26	563
Angeliki Ferti Greece	11	147 0.9×	37 0.2×	65 0.4×	59 0.5×	36 0.3×	21	344
Kinga B. Skowron United States	13	238 1.4×	52 0.3×	146 0.9×	74 0.7×	23 0.2×	18	416

Countries citing papers authored by Ingebjørg Knutsen

Since Specialization

Citations

This map shows the geographic impact of Ingebjørg Knutsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingebjørg Knutsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingebjørg Knutsen more than expected).

Fields of papers citing papers by Ingebjørg Knutsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingebjørg Knutsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingebjørg Knutsen. The network helps show where Ingebjørg Knutsen may publish in the future.

Co-authorship network of co-authors of Ingebjørg Knutsen

This figure shows the co-authorship network connecting the top 25 collaborators of Ingebjørg Knutsen. A scholar is included among the top collaborators of Ingebjørg Knutsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingebjørg Knutsen. Ingebjørg Knutsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Spurkland, Anne, S. Saarinen, Kirsten Muri Boberg, et al.. (1999). HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens. 53(5). 459–469. 121 indexed citations

Spurkland, Anne, et al.. (1997). The HLA‐DQ(α1*0102, β1*0602) heterodimer may confer susceptibility to multiple sclerosis in the absence of the HLA‐DR(α1*01, β1*1501) heterodimer. Tissue Antigens. 50(1). 15–22. 34 indexed citations

Spurkland, Anne, G. Ingvarsson, E S Falk, et al.. (1997). Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA‐DQ (α1*0501, (β1*02) or the HLA‐DQ (α1*03, (β1*0302) heterodimers. Tissue Antigens. 49(1). 29–34. 99 indexed citations

Zetterquist, Henrik, Mats Bengtsson, Niels Grunnet, et al.. (1997). REPORT FROM THE HLA CLASS II TYPING BY PCR‐SSP MULTICENTRE STUDY. European Journal of Immunogenetics. 24(3). 191–199. 11 indexed citations

Undlien, Dag E., Thomas Friede, Hans‐Georg Rammensee, et al.. (1997). HLA-Encoded Genetic Predisposition in IDDM: DR4 Subtypes May Be Associated With Different Degrees of Protection. Diabetes. 46(1). 143–149. 132 indexed citations

Knutsen, Ingebjørg, et al.. (1995). Serologic subtyping of HLA-DR8 by means of the cytotoxic human monoclonal antibody 5643. Human Immunology. 43(3). 200–206. 2 indexed citations

Spurkland, Anne, Ingebjørg Knutsen, A. Bratlie, et al.. (1995). Genomic HLA-DRB1 matching further improves clinical course after renal transplantation.. PubMed. 27(1). 678–9. 1 indexed citations

Breivik, Jarle, Gunn Iren Meling, Tobias Gedde‐Dahl, et al.. (1994). A K‐ras 13GLY → ASP mutation is recognized by HLA‐DQ7 restricted T cells in a patient with colorectal cancer. Modifying effect of DQ7 on established cancers harbouring this mutation?. International Journal of Cancer. 58(4). 506–511. 30 indexed citations

Spurkland, Anne, et al.. (1994). No association of multiple sclerosis to alleles at the TAP2 locus. Human Immunology. 39(4). 299–301. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact